BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27081658)

  • 1. Characteristics of cryptogenic stroke in cancer patients.
    Gon Y; Okazaki S; Terasaki Y; Sasaki T; Yoshimine T; Sakaguchi M; Mochizuki H
    Ann Clin Transl Neurol; 2016 Apr; 3(4):280-7. PubMed ID: 27081658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke.
    Gon Y; Sakaguchi M; Takasugi J; Kawano T; Kanki H; Watanabe A; Oyama N; Terasaki Y; Sasaki T; Mochizuki H
    Eur J Neurol; 2017 Mar; 24(3):503-508. PubMed ID: 28026909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of survival for patients with cancer after cryptogenic stroke.
    Shin YW; Lee ST; Jung KH; Kim DY; Park CK; Kim TM; Choi SH; Chu K; Lee SK
    J Neurooncol; 2016 Jun; 128(2):277-84. PubMed ID: 26968716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer.
    Nam KW; Kim CK; Kim TJ; An SJ; Demchuk AM; Kim Y; Jung S; Han MK; Ko SB; Yoon BW
    Eur J Neurol; 2017 Jan; 24(1):205-211. PubMed ID: 27766716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clues to occult cancer in patients with ischemic stroke.
    Kim SJ; Park JH; Lee MJ; Park YG; Ahn MJ; Bang OY
    PLoS One; 2012; 7(9):e44959. PubMed ID: 22984594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea.
    Kim SG; Hong JM; Kim HY; Lee J; Chung PW; Park KY; Kim GM; Lee KH; Chung CS; Bang OY
    Stroke; 2010 Apr; 41(4):798-801. PubMed ID: 20150545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer levels and cerebral infarction in critically ill cancer patients.
    Ryu JA; Bang OY; Lee GH
    BMC Cancer; 2017 Aug; 17(1):591. PubMed ID: 28854911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Alkaline Phosphatase in Cryptogenic Stroke Cases with Active Cancer.
    Izumi T; Nanaura H; Iguchi N; Ozaki M; Sugie K
    Intern Med; 2022; 61(5):639-646. PubMed ID: 35228475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
    Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH
    Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated ischemic stroke: A retrospective multicentre cohort study.
    Grazioli S; Paciaroni M; Agnelli G; Acciarresi M; Alberti A; D'Amore C; Caso V; Venti M; Guasti L; Ageno W; Squizzato A
    Thromb Res; 2018 May; 165():33-37. PubMed ID: 29558659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent foramen ovale and cryptogenic stroke in older patients.
    Handke M; Harloff A; Olschewski M; Hetzel A; Geibel A
    N Engl J Med; 2007 Nov; 357(22):2262-8. PubMed ID: 18046029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic stroke in patients with cancer: is it different from usual strokes?
    Lee EJ; Nah HW; Kwon JY; Kang DW; Kwon SU; Kim JS
    Int J Stroke; 2014 Jun; 9(4):406-12. PubMed ID: 23981525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Survival in Patients With Ischemic Stroke and Active Cancer: A Prospective, Multicenter, Observational Study.
    Gon Y; Sakaguchi M; Yamagami H; Abe S; Hashimoto H; Ohara N; Takahashi D; Abe Y; Takahashi T; Kitano T; Okazaki S; Todo K; Sasaki T; Hattori S; Mochizuki H;
    J Am Heart Assoc; 2023 Aug; 12(15):e029618. PubMed ID: 37489755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulopathy and embolic signal in cancer patients with ischemic stroke.
    Seok JM; Kim SG; Kim JW; Chung CS; Kim GM; Lee KH; Bang OY
    Ann Neurol; 2010 Aug; 68(2):213-9. PubMed ID: 20695014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the infarct pattern caused by vulnerable aortic arch atheroma: DWI and multidetector row CT study.
    Kim SJ; Ryoo S; Hwang J; Noh HJ; Park JH; Choe YH; Bang OY
    Cerebrovasc Dis; 2012; 33(6):549-57. PubMed ID: 22688060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential lesion patterns on T2-weighted magnetic resonance imaging and fluid-attenuated inversion recovery sequences in cryptogenic stroke patients with patent foramen ovale.
    Huang YY; Shao B; Ni XD; Li JC
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1690-5. PubMed ID: 24739592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale.
    Rodés-Cabau J; Noël M; Marrero A; Rivest D; Mackey A; Houde C; Bédard E; Larose E; Verreault S; Peticlerc M; Pibarot P; Bogaty P; Bertrand OF
    Stroke; 2009 Feb; 40(2):419-25. PubMed ID: 19095992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-related cryptogenic stroke involving the bilateral anterior and the posterior circulations: Diagnostic value of clinical and imaging characteristics.
    Xu Y; Wu Z; Xu H
    Front Neurol; 2022; 13():1032984. PubMed ID: 36578305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of finding occult atrial fibrillation after cryptogenic stroke.
    Favilla CG; Ingala E; Jara J; Fessler E; Cucchiara B; Messé SR; Mullen MT; Prasad A; Siegler J; Hutchinson MD; Kasner SE
    Stroke; 2015 May; 46(5):1210-5. PubMed ID: 25851771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of magnetic resonance imaging stroke recurrence in cryptogenic transient ischemic attack and minor stroke patients.
    Bal S; Patel SK; Almekhlafi M; Modi J; Demchuk AM; Coutts SB
    Stroke; 2012 Dec; 43(12):3387-8. PubMed ID: 23033345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.